The estimated Net Worth of Jason Rickard is at least $4.8 Million dollars as of 27 February 2023. Mr Rickard owns over 34,175 units of Ironwood Pharmaceuticals Inc stock worth over $1,447,019 and over the last 5 years he sold IRWD stock worth over $2,416,655. In addition, he makes $940,064 as COO & Sr. VP of Operations at Ironwood Pharmaceuticals Inc.
Mr has made over 14 trades of the Ironwood Pharmaceuticals Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 34,175 units of IRWD stock worth $388,228 on 27 February 2023.
The largest trade he's ever made was selling 47,477 units of Ironwood Pharmaceuticals Inc stock on 8 August 2022 worth over $554,531. On average, Mr trades about 10,639 units every 51 days since 2020. As of 27 February 2023 he still owns at least 332,648 units of Ironwood Pharmaceuticals Inc stock.
You can see the complete history of Mr Rickard stock trades at the bottom of the page.
Jason Rickard is the COO & Sr. VP of Operations at Ironwood Pharmaceuticals Inc.
As the COO & Sr. VP of Operations of Ironwood Pharmaceuticals Inc, the total compensation of Mr Rickard at Ironwood Pharmaceuticals Inc is $940,064. There are 5 executives at Ironwood Pharmaceuticals Inc getting paid more, with Mark Mallon having the highest compensation of $10,068,800.
Mr Rickard is 50, he's been the COO & Sr. VP of Operations of Ironwood Pharmaceuticals Inc since . There are 13 older and 5 younger executives at Ironwood Pharmaceuticals Inc. The oldest executive at Ironwood Pharmaceuticals Inc is Edward Owens, 73, who is the Independent Director.
Jason's mailing address filed with the SEC is C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110.
Over the last 15 years, insiders at Ironwood Pharmaceuticals Inc have traded over $83,928,361 worth of Ironwood Pharmaceuticals Inc stock and bought 2,478,676 units worth $24,100,589 . The most active insiders traders include Llc Fmr, Bryan E Roberts, and Alexander J Denner. On average, Ironwood Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $239,611. The most recent stock trade was executed by Minardo John on 12 August 2024, trading 9,910 units of IRWD stock currently worth $42,316.
ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b
Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include: